La Jolla Immunology Conference
- Assets
- $243.1k
- Revenue
- $104.0k
- Investments
- $0.0
- Employees
- 0
- Location
- La Jolla, CA
- Founding
- 01/2020
- Data as of
- 12/2022
- EIN
- 84-3705461
Organization Overview
La Jolla Immunology Conference is located in La Jolla, CA. The organization was established in 2020. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. LA Jolla Immunology Conference is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, LA Jolla Immunology Conference generated $104.0k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 3 years, the organization has seen revenues fall by an average of (22.0%) each year. All expenses for the organization totaled $53.7k during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE LA JOLLA IMMUNOLOGY CONFERENCE IS AN ANNUAL 3-DAY CONFERENCE WHICH BRINGS TOGETHER IMMUNOLOGISTS, PRIMARILY FROM SOUTHERN CALIFORNIA TO LEARN ABOUT AND DISCUSS THE LATEST FINDINGS IN IMMUNOLOGY AND FOSTERS COLLABORATIONS BETWEEN IMMUNOLOGISTS WORKING IN ACADEMIA AND INDUSTRY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN 2022, THE LA JOLLA IMMUNOLOGY CONFERENCE (LJIC) WAS A THREE DAY EVENT WHICH TAKES PLACE ANNUALLY, DRAWING ATTENDEES FROM ALL SECTORS OF THE IMMUNOLOGY COMMUNITY IN ORDER TO PRESENT THEIR RESEARCH AND SHARE IDEAS. THE CONFERENCE IN 2022, TOOK PLACE AT THE WORLD RENOWNED SALK INSTITUTE IN SAN DIEGO, CA FROM OCTOBER 25-27TH. THE TOPICS WERE"I. ECLECTIC IMMUNITYII. PROTECTIVE IMMUNITYIII. INNATE AND INNATE-LIKE IMMUNITYIV. CANCER AND ANTI-CANCER IMMUNITYV. MOLECULAR AND CELLULAR CONTROL OF THE IMMUNE SYSTEMFOR THIS EVENT, WE HAD FOUR SPONSORS AND REGISTRATION WAS FREE IN 2021.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Li-Fan Lu PHD Pres & Co-Chair | OfficerTrustee | 1 | $0 |
Hilde Cheroutre PHD VP - Chair | OfficerTrustee | 1 | $0 |
Manuela Raffatellu MD Director | Trustee | 0.5 | $0 |
Stephan Hedrick PHD Director | Trustee | 0.5 | $0 |
Linda Sherman PHD Director | Trustee | 0.5 | $0 |
David R Webb PHD Director | Trustee | 0.5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $103,990 |
| Investment income | $40 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $104,030 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $19,636 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $1,056 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $843 |
| Office expenses | $889 |
| Information technology | $6,825 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $3,323 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $11,764 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,388 |
| All other expenses | $25 |
| Total functional expenses | $53,683 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $72,887 |
| Savings and temporary cash investments | $170,251 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $243,138 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $243,138 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $243,138 |